nicotine has been researched along with Cytokine Release Syndrome in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benincasa, G; Cafiero, C; Micera, A; Palmirotta, R; Re, A; Schiavone, B | 1 |
| Ghobrial, RM; Kloc, M; Kubiak, JZ | 1 |
| Gonzalez-Rubio, J; Jimenez-Diaz, L; Lopez-Najera, A; Lopez-Najera, E; Najera, A; Navarro-Lopez, C; Navarro-Lopez, JD | 1 |
| Aschner, M; Copeland, RL; Getachew, B; Tizabi, Y | 1 |
| Liu, X; Qin, Z; Su, DF; Sun, Y; Xiang, K | 1 |
1 review(s) available for nicotine and Cytokine Release Syndrome
| Article | Year |
|---|---|
Nicotine and the nicotinic cholinergic system in COVID-19.
Topics: Angiotensin-Converting Enzyme 2; COVID-19; Cytokine Release Syndrome; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Lung; Nicotine; Receptors, Nicotinic; Receptors, Virus; SARS-CoV-2; Severity of Illness Index; Signal Transduction; Smoking; Spike Glycoprotein, Coronavirus | 2020 |
4 other study(ies) available for nicotine and Cytokine Release Syndrome
| Article | Year |
|---|---|
Comment on Kopańska et al. Disorders of the Cholinergic System in COVID-19 Era-A Review of the Latest Research.
Topics: Acetylcholine; Acetylcholinesterase; Antiviral Agents; Caffeine; COVID-19; Cytokine Release Syndrome; Humans; Muscle, Skeletal; Myasthenia Gravis; Nicotine; Protein Binding; Receptors, Nicotinic; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vagus Nerve | 2022 |
How nicotine can inhibit cytokine storm in the lungs and prevent or lessen the severity of COVID-19 infection?
Topics: Administration, Inhalation; alpha7 Nicotinic Acetylcholine Receptor; Anti-Inflammatory Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Cytokines; Host-Pathogen Interactions; Humans; Lung; Macrophages; Nicotine; Nicotinic Agonists; Pandemics; Pneumonia, Viral; Protective Factors; Receptors, Nicotinic; Risk Factors; SARS-CoV-2; Severity of Illness Index; Smokers | 2020 |
Cytokine Release Syndrome (CRS) and Nicotine in COVID-19 Patients: Trying to Calm the Storm.
Topics: alpha7 Nicotinic Acetylcholine Receptor; China; Cigarette Smoking; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Humans; Nicotine; Pandemics; Pneumonia, Viral; Severity of Illness Index | 2020 |
Activation of the Cholinergic Anti-Inflammatory Pathway as a Novel Therapeutic Strategy for COVID-19.
Topics: Acupuncture; Anti-Inflammatory Agents; COVID-19; Cytokine Release Syndrome; Cytokines; Drugs, Chinese Herbal; Humans; Inflammation; Neuroimmunomodulation; Nicotine; SARS-CoV-2; Solanaceous Alkaloids; Vagus Nerve; Vagus Nerve Stimulation | 2020 |